Ana Maria de Souza

Circulating Interleukin-6 and High-Sensitivity C-Reactive Protein Decrease After Periodontal Therapy in Otherwise Healthy Subjects

BACKGROUND Periodontal disease has been associated with many chronic inflammatory systemic diseases, and a common chronic inflammation pathway has been suggested for these conditions. However, few studies have evaluated whether periodontal disease, in the absence of other known inflammatory conditions and smoking, affects circulating markers of chronic inflammation. This study compared chronic inflammation markers in control individuals and patients with periodontal disease and observed whether non-surgical periodontal therapy affected inflammatory disease markers after 3 months. METHODS Plasma and serum of 20 controls and 25 patients with periodontal disease were obtained prior to and 3 months after non-surgical periodontal therapy. All patients were non-smokers, they did not use any medication, and they had no history or detectable signs and symptoms of systemic diseases. Periodontal and systemic parameters included probing depth, bleeding on probing, clinical attachment level, hematologic parameters, as well as the following inflammatory markers: interleukin (IL)-6, high-sensitivity C-reactive protein (hs-CRP), CD40 ligand, monocyte chemoattractant protein (MCP)-1, soluble P-selectin (sP-selectin), soluble vascular adhesion molecule (sVCAM)-1, and soluble intercellular adhesion molecule (sICAM)-1. RESULTS There were no differences in the hematologic parameters of the patients in the control and periodontal disease groups. Among the tested inflammatory markers, IL-6 concentrations were higher in the periodontal disease group at baseline compared to the controls (P = 0.006). Therapy was highly effective (P <0.001 for all the analyzed clinical parameters), and a decrease in circulating IL-6 and hs-CRP concentrations was observed 3 months after therapy (P = 0.001 and P = 0.006, respectively). Our results also suggest that the CD40 ligand marker may have been different in the control and periodontal disease groups prior to the therapy (P = 0.009). CONCLUSIONS In apparently otherwise healthy patients, periodontal disease is associated with increased circulating concentrations of IL-6 and hs-CRP, which decreased 3 months after non-surgical periodontal therapy. With regard to the CD40 ligand, MCP-1, sP-selectin, sVCAM-1, and sICAM-1, no changes were seen in the periodontal disease group between baseline and 3 months after therapy.

Time course of acute-phase response induced by Tityus serrulatus venom and TsTX-I in mice

Animal venom can induce systemic alterations similar to those observed in acute-phase inflammatory response. In the present study, we report the systemic (circulatory) and local (peritoneal cavity) effects induced by Tityus serrulatus venom and its major toxin TsTX-I (Ts1) in mice over various time periods. Both the venom and TsTX-I elicited quite similar responses in most assays. Responses included reduction of albumin, increased C-reactive protein, IL-6, IL-1alpha and TNF-alpha. Local and systemic leucocytosis, with a predominance of polymorphonuclear cells, was also observed. These effects show that a systemic inflammation-like syndrome is triggered during the severe envenomation caused by the T. serrulatus sting. The initial increases of albumin and total protein were probably consequences of the dehydration that occurs at the beginning of envenomation. Time-course analysis of these effects shows that responses are most pronounced on the first day after poisoning. However, leucocytosis and changes in acute-phase protein concentrations can be observed up to 7 days after envenomation.

Action of trivalent chromium on rat liver structure. Histometric and haematological studies

El cromo trivalente (Cr3+) es un nutriente esencial involucrado en la regulacion del metabolismo de carbohidratos, lipidos y proteinas, a traves de un estimulo a la accion de la insulina. El objetivo del presente trabajo fue caracterizar histopatologicamente e histometricamente las alteraciones hepaticas de ratas Wistar hembras, provocadas por la administracion de cromo III en agua potable. Ratas adultas recibieron racion y agua potable ad libitum, conteniendo 300 o 500 mg/l de cromo III, durante 4 meses. Los animales control recibieron solo agua y racion. Todos los animales fueron sacrificados con dosis letal de anestesico. Muestras de higado, fijadas en formol al 10% por 24 h, fueron cortadas a 6 µm y tenidas con hematoxilina y eosina o PAS. Ademas del examen histopatologico, fueron usadas tecnicas histometricas. La sangue fue recolectada y procesada para estudio hematologico. El analisis histopatologico revelo, en la zonas periportal, intermediaria y pericentrolobular, celulas parenquimatosas con grados variables de vacuolizacion. Muchos hepatocitos mostraban degeneracion baloniforme con nucleos lisados. La vena centrolobular estaba dilatada y congestionada. Se observaron sinusoides dilatados conteniendo eritrocitos. La zona porta mostro fibrosis y proliferacion de ductos biliares con pequenas celulas. La histometria mostro aumento de los volumenes de citoplasma y celular, y valores menores para el numero de hepatocitos por mm3. Linfopenia fue observada en los animales tratados con 500 mg/l de Cr3+. Estos resultados indican que el cromo III tiene una participacion directa en las alteraciones de las estructuras hepaticas

Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT

Dapsone (DDS) is useful in the treatment of a number of inflammatory conditions which are characterized by neutrophil infiltration. It is the drug of choice for the treatment of leprosy and prophylaxis of malaria. Haematological side effects of methaemoglobinaemia and haemolysis have been long recognized. However, the frequency and severity of these side effects in patients already treated with DDS as a single drug or as part of a multidrug therapy (MDT) have not been well documented. We report herein an investigation of the effect of dapsone long-term treatment on the haematological and biochemical alterations in leprosy patients undergoing dapsone as a single drug (DDS group) or as part of a multidrug therapy in combination with rifampin and clofazimine (MDT group). Methaemoglobinaemia and haemolytic anaemia were the principal side effects observed. Reticulocytes were found to be elevated (> 1.5%) in 90% of the patients. Heinz bodies were also detected (6.6% of the patients). The osmotic fragility test showed a reduction in cell resistance and in the evaluation of white cells a severe eosinophilia was found. Hepatic, pancreatic and renal evaluation by the determination of biochemical parameters showed rare and occasional changes of no apparent clinical significance. We conclude that haematological side effects of dapsone are significant even at doses currently used to treat leprosy (100 mg/day) and that rifampin and clofazimine do not increase the incidence of these effects during long-term treatment.

Phagocytosis and nitric oxide levels in rheumatic inflammatory states in elderly women.

Background: Very few studies have investigated, in the elderly, the effect of rheumatic inflammatory states on phagocyte function and free radical production. The objective of this article is to evaluate phagocytosis by neutrophils and the production of nitric oxide (·NO) by monocytes in elderly women recruited among patients of the Brazilian Public Health System. Methods: Forty patients aged more than 60 years with rheumatic inflammatory diseases were studied. Phagocytosis was measured by flow cytometry. ·NO production was measured by the total nitrite assay and conventional inflammation markers were determined. Data were analyzed with the Mann–Whitney nonparametric test and P<0.05 was considered significant. Results: C‐reactive protein levels and white blood cell counts were significantly higher in inflammation than in the control group (P<0.05). The phagocytosis fluorescence intensity per neutrophil and the percentual of neutrophils expressing phagocytosis were significantly higher (P<0.05) in the test than in the control group. Furthermore, there was significant ·NO overproduction by monocytes, (P<0.05). Conclusion: Phagocytosis and ·NO production are affected by rheumatic states. This suggests that the increased ·NO levels may play a part in the increased oxidative stress in rheumatic diseases in elderly women. J. Clin. Lab. Anal. 25:47–51, 2011.

Rare data on a rocky shore fish reproductive biology: sex ratio, length of first maturation and spawning period of Abudefduf saxatilis (Linnaeus, 1758) with notes on Stegastes variabilis spawning period (Perciformes: Pomacentridae) in São Paulo, Brazil

This study presents data on the reproduction of Abudefduf saxatilis, a rocky shore inhabitant at the northern coast of Sao Paulo State. A total of 73 individuals were collected using hooks and baits. They were measured, weighed and dissected, sex and maturation stage were analysed, first macroscopically, then part of the material was taken for microscopical confirmation. Visual censuses were also done for underwater observation of eggs presence. Results showed equivalence of males and females in the population, first maturation occurring between 101 and 115mm of total length, spawning period occurs from November to February for Abudefduf saxatilis and October to January for Stegastes variabilis. Reproductive period for A. saxatilis was positively related to air temperature and thermic amplitude, but the environmental clue most likely to influence this rhythm is photoperiod. Transects with visual census of males guarding eggs were also a reliable tool for finding reproductive period in these demersal, egg-guarder species.

Leucemia mielóide crônica e o sistema Fas-FasL

Abstract With therapeutic advances that include imatinib mesylate, bonemarrow transplantation and donor lymphocyte infusion, lifeexpectancy of chronic myeloid leukemia carriers has increasedsignificantly and the disease might not be fatal. However, thebiological mechanisms that favor the selection of malignant clonecells over normal cells, in most cases responsible for the lack oftherapeutic success, are still unclear. Alterations in cellular apoptosisprocess and escape of the leukemic cells from the anti-tumor immuneresponse can explain, in part, the selective advantages of these cells.The apoptosis process or programmed cell death can be triggeredby intrinsic or extrinsic pathways. The extrinsic is dependent on theinteraction of cell death receptors, such as the Fas receptor and itsagonist, the Fas ligand (FasL). A diminished expression of Fas andincreased of FasL in leukemic cell may increase its survival, therebymaking it resistant to apoptosis. This paper describes the relationbetween chronic myeloid leukemia and the Fas/FasL system andits possible importance in prognosis and in escape of the leukemiccells from the immune system. Rev. bras. hematol. hemoter. 2005;

BIOCHEMICAL AND HEMATOLOGICAL SIDE EFFECTS OF CLOFAZIMINE IN LEPROSY PATIENTS

Gastrointestinal toxicity and red skin discoloration were the major side effects observed in leprosy patients undergoing long-term treatment with clofazimine (CFZ). Hematological and biochemical alterations have been cited among other side effects; however, their real magnitude and clinical significance at the doses currently employed in therapy have not been sufficiently documented. We therefore investigated the correlation between CFZ plasma concentration and biochemical (transaminases, bilirubins, alkaline phosphatase, gamma-glutamyltransferase, amylase, urea, creatinine, and potassium plasma levels) as well as hematological changes blood and reticulocyte counts, osmotic fragility, detection of Heinz bodies and methemoglobinemia (MHM), following in two regimes of treatment: CFZ as a single drug and CFZ as part of multidrug (MDT) therapy, in combination with dapsone and rifampicin. MHM and hemolytic anemia were detected in the MDT group only. Eosinophilia was found in patients of either group. Determination of hepatic, pancreatic and renal biochemical parameters showed rare, occasional changes of apparently no clinical significance. We conclude that CFZ is a generally well tolerated and safe drug when given as a daily dose of 50mg, which is currently used in leprosy patients.

Altered erythropoiesis and iron metabolism in carriers of thalassemia.

The thalassemia syndromes (α‐ and β‐thalassemia) are the most common and frequent disorders associated with ineffective erythropoiesis. Imbalance of α‐ or β‐globin chain production results in impaired red blood cell synthesis, anemia, and more erythroid progenitors in the blood stream. While patients affected by these disorders show definitive altered parameters related to erythropoiesis, the relationship between the degree of anemia, altered erythropoiesis, and dysfunctional iron metabolism has not been investigated in both α‐thalassemia carriers (ATC) and β‐thalassemia carriers (BTC). Here, we demonstrate that ATC have a significantly reduced hepcidin and increased soluble transferrin receptor levels but relatively normal hematological findings. In contrast, BTC have several hematological parameters significantly different from controls, including increased soluble transferrin receptor and erythropoietin levels. These changes in both groups suggest an altered balance between erythropoiesis and iron metabolism. The index sTfR/log ferritin and (hepcidin/ferritin)/sTfR are, respectively, increased and reduced relative to controls, proportional to the severity of each thalassemia group. In conclusion, we showed in this study, for the first time in the literature, that thalassemia carriers have altered iron metabolism and erythropoiesis.

Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy

Background/Aims: We investigated the effects of tyrosine kinase inhibitors (TKIs) on the expression of apoptosis-related genes (BCL-2 and death receptor family members) in chronic myeloid leukemia (CML) patients. Methods: Peripheral blood mononuclear cells from 32 healthy subjects and 26 CML patients were evaluated before and after treatment with imatinib mesylate (IM) and dasatinib (DAS) by quantitative PCR. Results: Anti-apoptotic genes (c-FLIP and MCL-1) were overexpressed and the pro-apoptotic BIK was reduced in CML patients. Expression of BMF, A1, c-FLIP, MCL-1, CIAP-2 and CIAP-1 was modulated by DAS. In IM-resistant patients, expression of A1, c-FLIP, CIAP-1 and MCL-1 was upregulated, and BCL-2, CIAP-2, BAK, BAX, BIK and FASL expression was downregulated. Conclusion: Taken together, our results point out that, in CML, DAS interferes with the apoptotic machinery regulation. In addition, the data suggest that apoptosis-related gene expression profiles are associated with primary resistance to IM.